Picture EBD Group World of Partnering Opportunities 650x100px
Document › Details

va-Q-tec AG. (4/26/23). "Press Release: Sartorius and va-Q-tec Announce a Long-term Partnership for the Joint Development of Innovative Transport Systems for the Biopharmaceutical Industry". Würzburg & Göttingen.

Organisations Organisation va-Q-tec AG
  Group va-Q-tec (Group)
  Organisation 2 Sartorius AG
  Group Sartorius (Group)
Product Product laboratory equipment and instruments

> va-Q-tec and Sartorius are partnering to create a safer, simpler, and more sustainable TempChain-transportation system for active pharmaceutical ingredients (APIs) and bulk drug substance.

> The companies will combine their technologies to build an innovative transportation solution for international airfreight as well as intra-company shipments.

> This high-performance solution will be co-promoted globally by both companies.

va-Q-tec, a pioneer of highly efficient products and solutions in the field of thermal insulation, and Sartorius, a leading international supplier of technologies that help translate scientific discoveries into effective patient care, announced today a partnership to optimize logistics for shipping bulk drug substances (BDS). BDS are extremely temperature-sensitive and high-value goods and the partnership aims to increase efficiency and safety for BDS transportation throughout the industry. It comes after years of teamwork between Sartorius and va-Q-tec, leveraging the companies’ established position and respective expertise in the field.

Through this partnership, Sartorius’ new Celsius® single-use solutions for BDS management and va-Q-tec’s high-performing thermal insulated advanced passive containers (va-Q-tainers) are combined. This solution will provide the biopharmaceutical industry with a complete joint platform for the protection of hundred liters of frozen BDS shipments from outside temperatures, as well as mechanical and thermal stresses.

The solution features advanced insulation and phase change material, removing the need to use hazardous dry ice. It lowers the carbon emissions during transport and helps to make the temperature-controlled supply chain more climate-friendly. Thousands of va-Q-tainers are in operation worldwide through an international network of service centers that maintain and prepare each unit for the next shipment after deployment. Combined with Sartorius’ global supply chain, this network will make solutions and services easily accessible to customers worldwide. By avoiding overseas return trips between shipments, the network will also help streamline BDS transportation.

“High-quality products and processes in the pharmaceutical industry require the dedicated development work of proven experts, especially in the API logistics segment,” says Dr. Joachim Kuhn, CEO and founder of va-Q-tec. “We have gained a proven partner in Sartorius, with whom we will jointly set a targeted course to optimize transports and establish excellent processes as the standard.”

“An increasing amount of frozen bulk drug substance is being transported worldwide. This drives the need for more reliable and sustainable cold chain solutions,” says Eva Lindskog, Head of BA Fluid Management Technologies at Sartorius. “By leveraging our collaboration with va-Q-tec, Sartorius can now offer an integrated high-performance bulk drug substance transportation platform, for the benefit of customers globally.”

For more information on these technologies, please visit Celsius® FFT Platform | Sartorius and va-Q-tainer | va-Q-tec.

Record changed: 2024-01-06


Picture EBD Group World of Partnering Opportunities 650x200px

More documents for va-Q-tec (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Picture Berlin Partner Voices Martin Rahmel TU Berlin GreenChem 650x300px

» top